Search research articles
Contact Us
Filters
Showing results (81-90 of 499) with videos related to
Page
of 50
Sort By:
Journal of the Belgian Society of Radiology
|
July 25, 2020
Characterization of Liver Metastases During Catheter-Directed Liver Interventions: A Comparison between Dual Phase Cone-Beam Computed Tomography and Conventional Contrast-Enhanced Computed Tomography
Geert Maleux, Maria-Louisa Izamis, Cedric Werbrouck, et al.
Translational Oncology
|
December 18, 2016
Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response
Jeroen Dekervel, Ashenafi Bulle, Petra Windmolders, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 28, 2012
Mutant KRAS codon 12 and 13 alleles in patients with metastatic colorectal cancer: assessment as prognostic and predictive biomarkers of response to panitumumab
Marc Peeters, Jean-Yves Douillard, Eric Van Cutsem, et al.
Oncotargets and Therapy
|
August 9, 2020
Anti-Cancer Activity of Acriflavine as Metabolic Inhibitor of OXPHOS in Pancreas Cancer Xenografts
Ashenafi Bulle, Jeroen Dekervel, Lise Deschuttere, et al.
Journal of Translational Medicine
|
May 11, 2023
Human pancreatic cancer patients with Epithelial-to-Mesenchymal Transition and an aggressive phenotype show a disturbed balance in Protein Phosphatase Type 2A expression and functionality
Jos van Pelt, Bob Meeusen, Rita Derua, et al.
The Oncologist
|
February 17, 2024
Efficacy and Safety of Trifluridine/Tipiracil-Containing Combinations in Colorectal Cancer and Other Advanced Solid Tumors: A Systematic Review
Kohei Shitara, Alfred Falcone, Marwan G Fakih, et al.
The Lancet. Oncology
|
May 1, 2007
Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: a prospective study
Sabine Tejpar, Hubert Piessevaux, Kathleen Claes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2005
Epidermal growth factor receptor activity determines response of colorectal cancer cells to gefitinib alone and in combination with chemotherapy
Sandra Van Schaeybroeck, Anthi Karaiskou-McCaul, Donal Kelly, et al.
Annals of Surgical Oncology
|
March 28, 2012
Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome
Albert M Wolthuis, Freddy Penninckx, Karin Haustermans, et al.
Cancer Letters
|
November 1, 2012
Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth
Hannah van Malenstein, Jeroen Dekervel, Chris Verslype, et al.
Page
of 50
Search research articles
Search
Showing results (81-90 of 499) with videos related to
Sort By:
Page
of 50
Journal of the Belgian Society of Radiology
|
July 25, 2020
Characterization of Liver Metastases During Catheter-Directed Liver Interventions: A Comparison between Dual Phase Cone-Beam Computed Tomography and Conventional Contrast-Enhanced Computed Tomography
Geert Maleux, Maria-Louisa Izamis, Cedric Werbrouck, et al.
Translational Oncology
|
December 18, 2016
Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response
Jeroen Dekervel, Ashenafi Bulle, Petra Windmolders, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 28, 2012
Mutant KRAS codon 12 and 13 alleles in patients with metastatic colorectal cancer: assessment as prognostic and predictive biomarkers of response to panitumumab
Marc Peeters, Jean-Yves Douillard, Eric Van Cutsem, et al.
Oncotargets and Therapy
|
August 9, 2020
Anti-Cancer Activity of Acriflavine as Metabolic Inhibitor of OXPHOS in Pancreas Cancer Xenografts
Ashenafi Bulle, Jeroen Dekervel, Lise Deschuttere, et al.
Journal of Translational Medicine
|
May 11, 2023
Human pancreatic cancer patients with Epithelial-to-Mesenchymal Transition and an aggressive phenotype show a disturbed balance in Protein Phosphatase Type 2A expression and functionality
Jos van Pelt, Bob Meeusen, Rita Derua, et al.
The Oncologist
|
February 17, 2024
Efficacy and Safety of Trifluridine/Tipiracil-Containing Combinations in Colorectal Cancer and Other Advanced Solid Tumors: A Systematic Review
Kohei Shitara, Alfred Falcone, Marwan G Fakih, et al.
The Lancet. Oncology
|
May 1, 2007
Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: a prospective study
Sabine Tejpar, Hubert Piessevaux, Kathleen Claes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2005
Epidermal growth factor receptor activity determines response of colorectal cancer cells to gefitinib alone and in combination with chemotherapy
Sandra Van Schaeybroeck, Anthi Karaiskou-McCaul, Donal Kelly, et al.
Annals of Surgical Oncology
|
March 28, 2012
Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome
Albert M Wolthuis, Freddy Penninckx, Karin Haustermans, et al.
Cancer Letters
|
November 1, 2012
Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth
Hannah van Malenstein, Jeroen Dekervel, Chris Verslype, et al.
Page
of 50